PROCHYMAL® (Human Adult Stem Cells) for the Treatment of Recently Diagnosed Type 1 Diabetes Mellitus (T1DM)

Clinical Trial ID NCT00690066

Rank	Title	Journal	Year	PubWeight™‹?›
1	Immunotherapy for the prevention and treatment of type 1 diabetes: human trials and a look into the future.	Diabetes Care	2009	1.20
2	Immunological applications of stem cells in type 1 diabetes.	Endocr Rev	2011	1.20
3	Mesenchymal Stem Cells: Rising Concerns over Their Application in Treatment of Type One Diabetes Mellitus.	J Diabetes Res	2015	0.95
4	Stem cell therapy to cure type 1 diabetes: from hype to hope.	Stem Cells Transl Med	2013	0.93
5	Potential clinical applications of adult human mesenchymal stem cell (Prochymal®) therapy.	Stem Cells Cloning	2011	0.93
6	Cell-based interventions to halt autoimmunity in type 1 diabetes mellitus.	Clin Exp Immunol	2013	0.84
7	Efforts to prevent and halt autoimmune beta cell destruction.	Endocrinol Metab Clin North Am	2010	0.78
8	Concise Review: Cell-Based Therapies and Other Non-Traditional Approaches for Type 1 Diabetes.	Stem Cells	2016	0.76
9	Diabetes mellitus and cellular replacement therapy: Expected clinical potential and perspectives.	World J Diabetes	2014	0.76